Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial

Background. A new agent, potassium-competitive acid blocker vonoprazan (VPZ) has potent acid-inhibitory effects and may offer advantages over conventional H. pylori eradication therapies. We aimed to compare the eradication rate between VPZ-based treatment and PPI-based one. Methods. This randomized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can J Gastroenterol Hepatol
Main Authors: Maruyama, Masafumi, Tanaka, Naoki, Kubota, Daisuke, Miyajima, Masayuki, Kimura, Takefumi, Tokutake, Koujiro, Imai, Ryujiro, Fujisawa, Toru, Mori, Hiromitsu, Matsuda, Yoshiaki, Wada, Shuichi, Horiuchi, Akira, Kiyosawa, Kendo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2017
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5350398/
https://ncbi.nlm.nih.gov/pubmed/28349044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4385161
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados